Literature DB >> 33914970

Treatment-resistant bullous pemphigoid developing during therapy with immune checkpoint inhibitors.

E Povilaityte1, F F Gellrich1, S Beissert1, S Abraham1, F Meier1,2, C Günther1.   

Abstract

Entities:  

Year:  2021        PMID： 33914970     DOI： 10.1111/jdv.17321

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  2 in total

Review 1.  High Grade Dermatologic Adverse Events Associated With Immune Checkpoint Blockade for Cancer.

Authors:  Alyce M Kuo; Alina Markova
Journal:  Front Med (Lausanne)       Date:  2022-06-13

Review 2.  Lichen planus pemphigoides: A unique form of bullous and lichenoid eruptions secondary to nivolumab.

Authors:  Rohan R Shah; Chinmoy Bhate; Amanda Hernandez; Chin Hung Ho
Journal:  Dermatol Ther       Date:  2022-03-15       Impact factor: 3.858
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.